21. |
22. |
23. |
24. |
25. |
26. |
27. Go for Mura : upravljanje poplavnih gozdov v območjih Natura 2000 ob MuriŠpela Ambrožič, Gregor Božič, Maarten De Groot, Andreja Ferreira, Tatjana Gregorc, Marjana Hönigsfeld Adamič, Anže Japelj, Andrej Kapla, Marko Kovač, Štefan Kovač, Lado Kutnar, Tom Levanič, Boštjan Mali, Aleksander Marinšek, Zdenka Mazej, Nikica Ogris, Špela Planinšek, Mitja Skudnik, Gabrijela Triglav Brežnik, Saša Vochl, Al Vrezec, 2017, strokovna monografija Povzetek: Vsebina publikacije na kratko povzema izsledke projekta Go for Mura. Predstavljeni so poplavni in močvirni gozdovi ob Muri, njihov pomen ter različni vidiki omenjenih gozdov, ki so bili raziskani tekom projekta. Predstavljene so ostale aktivnosti projekta .
Ključne besede: Natura 2000, gospodarjenje, poškodovanost gozdov, poplavni gozd, Slovenija
Objavljeno v DiRROS: 18.01.2021; Ogledov: 1585; Prenosov: 475
 Celotno besedilo (2,27 MB) |
28. Documenting metrological traceability as intended by ISO 15189:2012 : a consensus statement about the practice of the implementation and auditing of this norm elementMarc H. M. Thelen, Florent Vanstapel, Pika Meško-Brguljan, Bernard Gouget, Guilaine Boursier, Edward Barrett, Christos Kroupis, Maria Lohmander, Luděk Šprongl, Tatjana Vodnik, 2019, izvirni znanstveni članek Povzetek: ISO15189:2012 requires medical laboratories to document metrological traceability of their results. While the ISO17511:2003 standard on metrological traceability in laboratory medicine requires the use of the highest available level in the traceability chain, it recognizes that for many measurands there is no reference above the manufacturer's selected measurement procedure and the manufacturer's working calibrator. Some immunoassays, although they intend to measure the same quantity and may even refer to the same reference material, unfortunately produce different results because of differences in analytical selectivity as manufacturers select different epitopes and antibodies for the same analyte. In other cases, the cause is the use of reference materials, which are not commutable. The uncertainty associated with the result is another important aspect in metrological traceability implementation. As the measurement uncertainty on the clinical samples is influenced by the uncertainty of all steps higher in the traceability chain, laboratories should be provided with adequate and appropriate information on the uncertainty of the value assignment to the commercial calibrators that they use. Although the between-lot variation in value assignment will manifest itself as part of the long-term imprecision as estimated by the end-user, information on worst-case to be expected lot-lot variation has to be communicated to the end-user by the IVD provider. When laboratories use ancillary equipment that potentially could have a critical contribution to the reported results, such equipment needs verification of its proper calibration and criticality to the result uncertainty could be assessed by an approach based on risk analysis, which is a key element of ISO15189:2012 anyway. This paper discusses how the requirement for metrological traceability as stated in ISO15189 should be met by the medical laboratory and how this should be assessed by accreditation bodies.
Ključne besede: laboratories, medical laboratory science, risk management, quality control, quality improvement, health care quality assurance, metrological traceability
Objavljeno v DiRROS: 22.10.2020; Ogledov: 1263; Prenosov: 279
 Povezava na datoteko |
29. Prevalence of and factors associated with healthcare-associated infections in Slovenian acute care hospitals : results of the third national surveyIrena Klavs, Mojca Serdt, Aleš Korošec, Tatjana Lejko-Zupanc, Blaž Pečavar, 2019, izvirni znanstveni članek Povzetek: Introduction. In the third Slovenian national healthcare-associated infections (HAIs) prevalence survey, conducted within the European point prevalence survey of HAIs and antimicrobial use in acute care hospitals, we estimated the prevalence of all types of HAIs and identified factors associated with them. Methods. Patients were enrolled into a one-day cross-sectional study in November 2017. Descriptive analyses were performed to describe the characteristics of patients, their exposure to invasive procedures and the prevalence of different types of HAIs. Univariate and multivariate analyses of association of having at least one HAI with possible risk factors were performed to identify risk factors. Results. Among 5,743 patients, 4.4% had at least one HAI and an additional 2.2% were still treated for HAIs on the day of the survey, with a prevalence of HAIs of 6.6%. The prevalence of pneumoniae was the highest (1.8%), followed by surgical site infections (1.5%) and urinary tract infections (1.2%). Prevalence of blood stream infections was 0.3%. In intensive care units (ICUs), the prevalence of patients with at least one HAI was 30.6%. Factors associated with HAIs included central vascular catheter (adjusted odds ratio [aOR] 4.1; 95% confidence intervals [CI]: 3.1–5.4), peripheral vascular catheter (aOR 3.0; 95% CI: 2.3–3.9), urinary catheter (aOR 1.8; 95% CI: 1.4–2.3). Conclusions. The prevalence of HAIs in Slovenian acute care hospitals in 2017 was substantial, especially in ICUs. HAIs prevention and control is an important public health priority. National surveillance of HAIs in ICUs should be developed to support evidence-based prevention and control.
Ključne besede: healthcare-associated infections, prevalence, survey, risk factors, Slovenia
Objavljeno v DiRROS: 16.10.2020; Ogledov: 2378; Prenosov: 889
Celotno besedilo (255,15 KB)
Gradivo ima več datotek! Več... |
30. |
